Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for stomach pain? itopride study targets Post-Meal distress

NCT ID NCT07165301

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times

Summary

This study follows 200 adults with functional dyspepsia (stomach discomfort without a clear cause) who are prescribed itopride as part of their normal care. Researchers will track symptom changes like fullness, bloating, and pain over 16 weeks using a standard questionnaire. The goal is to see how well itopride works in real-world Western patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UZ Leuven

    Leuven, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.